Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review

doi:10.4330/wjc.v18.i1.111954

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 1

This Article

(32)

(37)

(0)

(11)

(1332)

(15)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Cardiol. Jan 26, 2026; 18(1): 111954
Published online Jan 26, 2026. doi: 10.4330/wjc.v18.i1.111954

Full Size Figure Download Figure

Figure 4 Pathophysiological mechanisms of obesity/hyperlipidemia on the risk of development of metabolic dysfunction-associated liver disease and heart failure with preserved ejection fraction. DAG: Diacylglycerol; HFpEF: Heart failure with preserved ejection fraction; IL-6: Interleukin-6; JAK: Janus kinase; LV: Left ventricle; PPAR: Peroxisome proliferator activated receptor; PUFA: Polyunsaturated fatty acid; ROS: Reactive oxygen species; TAG: Triacylglycerol.

Citation: Brar AS, Khanna T, Sohal A, Hatwal J, Sharma V, Singh C, Batta A, Chandra P, Mohan B. Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review. World J Cardiol 2026; 18(1): 111954
URL: https://www.wjgnet.com/1949-8462/full/v18/i1/111954.htm
DOI: https://dx.doi.org/10.4330/wjc.v18.i1.111954

Brar AS, Khanna T, Sohal A, Hatwal J, Sharma V, Singh C, Batta A, Chandra P, Mohan B. Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review. World J Cardiol 2026; 18(1): 111954 [PMID: 41607621 DOI: 10.4330/wjc.v18.i1.111954]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.